Anika Therapeutics ANIK
NASDAQ ANIK
$19.10 -0.26 (-1.34%)
At close: Oct 2, 2026 · 4:00 PM EDT

Anika Therapeutics (ANIK) Asset Writedowns and Impairment (2010 - 2026)

Updated

Anika Therapeutics (ANIK) recorded Asset Writedowns and Impairment of $1.54 million in Q2 2026, down 48.7% from $3.01 million a year earlier but up 49.5% from the prior quarter.

Analysis

Anika Therapeutics (ANIK) Asset Writedowns and Impairment (2010 - 2026) Analysis & Trends

On a TTM basis, Anika Therapeutics' Asset Writedowns and Impairment came in at $4.55 million as of Jun 30, 2026, down 82.2% year-over-year; for FY2025, it came in at $5.82 million, down 87.0% from FY2024.

  • Annual Asset Writedowns and Impairment has a five-year compound annual growth rate of -32.8% (FY2020 to FY2025).
  • Across earlier years, Asset Writedowns and Impairment came in at $44.71 million in FY2024 (-28.1%), $62.19 million in FY2023, $5.33 million in FY2022 (-19.6%) and $6.63 million in FY2021 (-84.4%).
  • Quarterly Asset Writedowns and Impairment has ranged from $89,000 in Q2 2022 to $59.58 million in Q4 2023 over the past five years.
  • On a year-over-year basis, Asset Writedowns and Impairment rose in two of the last seven quarters, with growth averaging 4.8%.
  • Peak year-over-year performance for Asset Writedowns and Impairment in the last five years was growth of 600.0% in Q2 2023, against a decline of 95.4% in Q4 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $1.03 million (Q1 2026), $852,000 (Q4 2025) and $1.13 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn
10 Anika Therapeutics 255.62 Mn -10.93 Mn 21.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.54 Mn
Mar 31, 2026 1.03 Mn
Dec 31, 2025 852,000.00
Sep 30, 2025 1.13 Mn
Jun 30, 2025 3.01 Mn
Mar 31, 2025 832,000.00
Dec 31, 2024 18.63 Mn
Sep 30, 2024 3.10 Mn
Jun 30, 2024 675,000.00
Mar 31, 2024 2.06 Mn
Dec 31, 2023 59.58 Mn
Jun 30, 2023 623,000.00
Mar 31, 2023 629,000.00
Dec 31, 2022 1.63 Mn
Sep 30, 2022 3.03 Mn
Jun 30, 2022 89,000.00
Mar 31, 2022 586,000.00
Dec 31, 2021 2.93 Mn
Jun 30, 2021 400,000.00
Mar 31, 2021 277,000.00
API Access

Anika Therapeutics Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=ANIK&period=max&api_key=YOUR_API_KEY